← Back to catalogue

APEX RF System

FDA UDI

Class II (US FDA UDI)

by Inmode MD , Ltd.

Identity

Trade Name
APEX RF System FDA UDI
Generic Name
Percutaneous radio-frequency ablation system generator FDA UDI
Device Name
Apex RF system employs radiofrequency (RF) energy and Electrical Muscle Stimulation (EMS) technology for various aesthetic and medical application. FDA UDI
Model / Reference
AG614329A FDA UDI
Description
Apex RF system employs radiofrequency (RF) energy and Electrical Muscle Stimulation (EMS) technology for various aesthetic and medical application. FDA UDI

Identifiers

Catalog Number
AG614329A FDA UDI
Primary DI / UDI-DI
07290019863342 FDA UDI
510(k) Number
K210492 FDA UDI
FDA Product Code
GEI FDA UDI
PBX FDA UDI
ISA FDA UDI
NUV FDA UDI
GMDN Term
Percutaneous radio-frequency ablation system generator FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
878.4400 FDA UDI
890.5660 FDA UDI
878.4810 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

Yes

FDA UDI

Category: Percutaneous radio-frequency ablation system generator

APEX RF System by Inmode MD , Ltd. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Percutaneous radio-frequency ablation system generator.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Inmode MD , Ltd.

Sources (1)

  • FDA UDI 42112640-3d77-4a31-a71a-0976cdafbbae 37 fields · synced Jun 8, 2026